
腎移植,腎髒移植
With the development of immunosuppressive drugs, the risk of infection is increasing after renal transplantation.
隨着免疫抑制劑的發展,腎移植術後發生感染的風險在逐漸提高。
The aim of this study was to investigate frequency and histomorphometric pattern of bone disease after renal transplantation.
本研究的目的是探讨腎移植後骨科疾病發生的頻率和形态組織學特征。
This study evaluated the effect and safety of Nateglinide on impaired glucose tolerance after renal transplantation, and compares them with Acarbose.
觀察那格列奈治療腎移植術後糖耐量異常的臨床療效及安全性,并與阿卡波糖相比較。
Methods To analyze clinical data of 13 patients suffering from tuberculosis infection after renal transplantation retrospectively.
方法回顧性分析13例腎移植術後并發結核感染患者的臨床資料。
Objective To investigate the significance of human leukocyte antigen matching in highly sensitized recipients of renal transplantation.
目的探讨人類白細胞抗原配型在高緻敏受者腎髒移植中的臨床意義。
Objective:To explore the relationship between chimera generated from donator bone marrow infusion and acute rejection in renal transplantation.
目的:探讨供體骨髓輸注發生嵌合體與腎移植急性排斥反應的關系及其臨床意義。
Objective To investigate the significance of human leukocyte antigen (HLA) matching in highly sensitized recipients of renal transplantation.
目的探讨人類白細胞抗原(HLA)配型在高緻敏受者腎髒移植中的臨床意義。
CONCLUSION: Zenapax used for immunity induction of renal transplantation can prevent and reduce the occurrence of acute reject reaction, it has safety and good tolerance.
結論:賽尼哌用于腎移植的免疫誘導治療,可以預防和減少急性排斥反應的發生,安全性和耐受性好。
Objective:To compare the clinical outcomes of renal transplantation with or without dialysis in uremic patients, in an effort to assess the feasibility of renal transplantation without dialysis.
目的:觀察尿毒症患者未經透析直接行腎移植的臨床療效,并與透析後腎移植患者比較,探讨無透析腎移植的臨床可行性。
Objective To analyse the clinical risk factors of multiple organ dysfunction syndrome(MODS) after renal transplantation.
目的探讨腎移植術後多器官功能障礙綜合征(MODS)的臨床危險因素。
The chronic renal failure chiefly depends on dialyse or renal transplantation to elongate life at present , but the two ways do not work out a solution really and cost much.
慢性腎功能衰竭目前主要依靠透析或腎移植替代療法來延長生命,但二者并未徹底解決問題并且代價昂貴。
Objective To observe the immunosuppression function of a novel HLA-derived peptide, RDP1258, after rat renal transplantation in vivo.
目的觀察一種新型的人類白細胞抗原衍生肽(RDP1258)對大鼠腎移植後的免疫抑制作用。
OBJECTIVE: To observe clinical curative effect, the safety and tolerance of zenapax used for immunity induction of renal transplantation.
目的:分析觀察賽尼哌用于腎移植免疫誘導的臨床療效及其安全性和耐受性。
Objective To study the management of stoma hemorrhage after renal transplantation.
目的探讨腎移植術後吻合口出血的處理。
The suitability of regular dialysis or renal transplantation for patients with amyloidosis therefore arises.
因此提出了在腎澱粉樣變性病患者中常規血透或腎移植的適合性。
METHODS :HPLC method was employed to determine the total and free MPA plasma concentrations at different time points in 13 renal transplantation patients after taking mycophenolate mofetil.
方法:采用高效液相色譜法測定13例腎移植病人服用麥考酚酸酯後不同時間點的總的和遊離的MPA血藥濃度。
Objective: To observe the early enteral nutrition results after renal transplantation.
目的觀察腎移植術後早期腸内營養支持的效果。
To analysed the existing problems and faced difficulties of renal transplantation in China and propose the corresponding countermeasures.
分析了我國腎髒移植存在的問題和面臨的困難,并提出相應的對策。
Conclusions To avoid specific antibody through HLA matching is the key point for successful renal transplantation of HSP.
結論避開相應抗體的良好HLA配型,是高度緻敏受者腎移植成功的關鍵。
Purpose:To investigate the causes and prophylaxis of the percutaneous lymphorrhagia and iliac fossa lymphocele after cadaver renal transplantation.
目的:探讨屍腎移植術後發生傷口淋巴漏和髂窩淋巴囊腫的原因及其防治方法。
To study the diagnosis of cytomegalovirus (CMV) infection after renal transplantation and the effects and side effects of preventive use of foscarnet (PFA).
研究腎移植術後巨細胞病毒(CMV)感染的診斷及預防性使用膦甲酸鈉(PFA)治療的療效與毒副作用。
Objective To compare the clinical outcomes of preemptive renal transplantation and transplantation after dialysis, and to evaluate the safety and advantages of preemptive renal transplantation.
目的比較透析後腎移植與無透析腎移植的臨床效果,探讨無透析腎移植的安全性與優越性。
Objective To clarify the impacts of early graft function on the long-term outcome of cadaveric renal transplantation.
目的探讨腎移植術後早期腎功能恢複情況對人腎長期存活的影響。
Conclusion Results uremia after renal transplantation in patients with left ventricular structure and function gradually improved.
結論尿毒症患者腎移植術後,左室結構和功能逐漸得以改善。
AIM:To investigate limited sampling strategies (LSS) for clinical plasma monitoring of mycophenolic acid (MPA) in renal transplantation patients.
目的:制訂腎移植病人中麥考酚酸(MPA)的血藥濃度監測的有限采樣法方案。
Objective:To investigate the effect of early graft function on graft survival after renal transplantation.
目的:分析腎移植術後早期不同的腎功能狀态對移植腎長期存活的影響。
Objective To establish a ****** and reliable renal transplantation model.
目的建立一種簡便可靠的大動物腎移植模型。
腎移植(renal transplantation)是一種通過手術将健康腎髒植入患者體内,替代已喪失功能的腎髒的醫療手段。該手術主要適用于終末期腎病患者,當其他治療方式(如透析)無法維持生命時,可作為長期解決方案。
根據美國國家腎髒基金會(NKF)的定義,腎移植的供體可分為兩類:
世界衛生組織(WHO)數據顯示,成功的腎移植可使患者5年生存率達到85%以上,顯著高于透析治療的生存率。手術需進行嚴格的組織配型,包括HLA抗原檢測和交叉配型試驗,以降低排斥反應風險。
術後需終身使用免疫抑制劑,如他克莫司和黴酚酸酯,同時監測腎功能指标。梅奧診所(Mayo Clinic)指出,現代腎移植技術已使急性排斥反應發生率降至10%以下。常見并發症包括感染風險增加、代謝紊亂和心血管疾病,需通過多學科團隊進行長期管理。
Renal Transplantation(腎移植)是指通過外科手術将健康的腎髒移植到患者體内,以替代喪失功能的腎髒。以下是詳細解釋:
基本定義
該術語由兩部分構成:
類型與適應症
手術與術後管理
存活率與效果
根據臨床數據,異體腎移植的1年存活率可達95%以上,是終末期腎病最有效的治療手段之一。
相關擴展
如需更完整的醫學定義或研究數據,可參考權威醫學文獻或移植中心指南。
【别人正在浏覽】